Feline Cerebrovascular Disease (Ischemic Stroke)

Feline cerebrovascular disease (ischemic stroke) is a neurological condition defined as any abnormality of the brain resulting from a pathologic process affecting its blood supply [1]. Ischemic stroke specifically results from occlusion of a cerebral blood vessel by a thrombus or embolism, depriving affected brain tissue of oxygen and glucose, ultimately leading to neuronal death in the ischemic territory [1]. The condition is increasingly recognized in cats, partly due to the wider availability of advanced imaging technologies such as magnetic resonance imaging (MRI), which allows definitive diagnosis during life [2]. While historically underdiagnosed, feline ischemic stroke represents a clinically significant cause of acute neurological dysfunction and warrants prompt veterinary evaluation.

Pathophysiology of Ischemic Stroke

Ischemic stroke results from interruption of blood flow to a region of the brain, causing a cascade of injurious events beginning within minutes of onset [1]. The brain is critically dependent on continuous blood flow to supply oxygen and glucose; even brief interruption leads to neuronal dysfunction, and prolonged ischemia results in irreversible infarction [2]. The ischemic core (the area of most severely reduced perfusion) undergoes necrosis, while the surrounding penumbra — tissue with reduced but not completely absent perfusion — remains potentially salvageable if perfusion is restored promptly [2].

At the cellular level, failure of ATP-dependent ion pumps leads to membrane depolarization, calcium influx, excitotoxic neurotransmitter release (particularly glutamate), free radical generation, and ultimately cell death [1]. Experimental middle cerebral artery occlusion (MCA) studies in cats have demonstrated that neurological severity correlates with the degree and duration of EEG amplitude reduction following vessel occlusion, with severe stroke cases showing persistent EEG suppression and greater morphological damage [3].

Advanced imaging techniques such as diffusion-weighted MRI (DWI) and susceptibility-weighted imaging (SWI) reveal early ischemic changes; SWI in particular has demonstrated prominent hypointense veins within the ischemic territory of cats with acute infarction, suggesting significant venous deoxygenation and hemodynamic compromise in the affected region [5]. Proton MR spectroscopy studies confirm metabolic disruption in ischemic brain tissue, including decreased N-acetylaspartate (reflecting neuronal loss) and elevated lactate (reflecting anaerobic glycolysis) [4].

Underlying Causes and Risk Factors

Unlike humans, where atherosclerosis is the dominant cause, feline ischemic stroke most often results from an identifiable underlying systemic disease [1]. Known or suspected etiologies include:

• ·Hypertension (systemic arterial hypertension) — the most commonly identified risk factor in cats; hypertension can precipitate thromboembolism or direct vascular injury
• ·Hyperthyroidism — frequently associated with hypertension and a hypercoagulable state
• ·Chronic kidney disease (CKD) — associated with hypertension and uremia-related endothelial dysfunction
• ·Cardiac disease and cardiomyopathy — sources of cardiac thrombi that may embolize to cerebral vessels
• ·Hypercoagulable states — including protein-losing nephropathy, neoplasia, or polycythemia
• ·Neoplasia — either direct vascular invasion or thromboembolic complications
• ·Parasitic migration — aberrant larval migration (e.g., Cuterebra larvae causing feline ischemic encephalopathy, a distinct but related entity)
• ·Idiopathic causes — in a substantial proportion of cases, no underlying etiology is identified despite thorough investigation [1]

Clinical Assessment

Diagnosis begins with a thorough history and neurological examination. The hallmark of ischemic stroke is the peracute to acute onset of non-progressive (or improving) focal neurological deficits in a cat that was normal immediately prior [1]. Neurolocalization (identifying the affected region of the nervous system) is essential to guide imaging and interpret findings appropriately.

Laboratory Diagnostics

A complete minimum database is essential to identify potential underlying causes and rule out metabolic mimics. Relevant laboratory parameters include:

• ·

  Complete Blood Count (CBC):

  • ·Hematocrit (HCT): Elevated HCT (polycythemia) increases blood viscosity and thrombotic risk; severe anemia can precipitate hypoxic-ischemic injury
  • ·Platelet count (PLT): Thrombocytosis may predispose to thromboembolism; thrombocytopenia raises hemorrhagic stroke concern
  • ·WBC: Leukocytosis may suggest concurrent infectious or inflammatory disease
• ·

  Serum Biochemistry:

  • ·BUN and CREA (Creatinine): Elevated values suggest chronic kidney disease, a major risk factor for hypertension and stroke
  • ·ALT: Elevated values may indicate hepatic disease contributing to coagulopathy
  • ·Total bilirubin (TBIL): Hyperbilirubinemia may indicate hemolytic or hepatic disease
  • ·Albumin (ALB): Hypoalbuminemia (e.g., protein-losing nephropathy) is a significant hypercoagulable risk factor
  • ·Globulins (GLOB): Hyperglobulinemia may suggest inflammatory or neoplastic disease
  • ·Total T4: Should be measured in all middle-aged to older cats to screen for hyperthyroidism
• ·

  Urinalysis: Proteinuria (UPC ratio) screens for protein-losing nephropathy, a major hypercoagulable risk factor

• ·

  Blood pressure measurement: Systolic hypertension (>160–180 mmHg) is a critical finding and should be assessed in all suspected stroke patients [1]

• ·

  Coagulation profile (PT, aPTT): To assess coagulopathy

• ·

  Thoracic radiographs and echocardiography: To evaluate for cardiac disease as a source of emboli

Neuroimaging

MRI is the gold standard for diagnosis and is strongly preferred over CT for evaluation of brain parenchyma [1] [2]. Key MRI sequences include:

• ·Diffusion-Weighted Imaging (DWI): Most sensitive for acute ischemic infarction within hours of onset; restricted diffusion (bright on DWI, dark on ADC map) is characteristic [5]
• ·Susceptibility-Weighted Imaging (SWI): Demonstrates prominent hypointense veins in the ischemic territory of cats with acute infarction, reflecting venous oxygen depletion; also identifies hemorrhagic transformation [5]
• ·T2-weighted and FLAIR sequences: Show hyperintense signal in the affected region, typically becoming more apparent 24–48 hours after onset
• ·Perfusion-weighted imaging (PWI): Can depict the hypoperfused penumbra and ischemic core, providing information about tissue at risk [2]
• ·MR Spectroscopy (1H-MRS): Reveals decreased N-acetylaspartate and elevated lactate in ischemic tissue, confirming metabolic compromise [4]
• ·T2 / GRE sequences:* Detect microhemorrhages and distinguish ischemic from hemorrhagic stroke

CT scan is more readily available but is less sensitive for acute ischemia and posterior fossa lesions; it is primarily useful for excluding hemorrhage in emergency settings.

Differential Diagnoses

Key differentials to exclude include intracranial neoplasia, infectious meningoencephalitis (e.g., FIP, Toxoplasma, Cryptococcus), feline ischemic encephalopathy (Cuterebra-related), inflammatory encephalitis, and epileptic seizure with post-ictal deficits.

There is currently no proven, specific reperfusion therapy (such as tPA thrombolysis) validated for clinical use in cats, and management is primarily supportive and targeted at underlying causes [1]. Treatment goals include minimizing secondary brain injury, managing concurrent disease, and providing nursing care during recovery.

Management of Underlying Causes

• ·Antihypertensive therapy: Amlodipine (0.625–1.25 mg/cat PO q24h) is the first-line antihypertensive agent in cats; prompt blood pressure control is critical to prevent recurrence and ongoing vascular injury [1]
• ·Hyperthyroidism treatment: Methimazole, radioactive iodine, or surgical thyroidectomy as appropriate
• ·Cardiac disease management: Appropriate cardiac medications (e.g., atenolol, clopidogrel for thromboembolism prevention in cardiomyopathy patients)
• ·CKD management: Dietary modification, phosphate binders, subcutaneous fluids as needed

Neuroprotective and Symptomatic Therapy

• ·Corticosteroids: Controversial and generally not recommended for ischemic stroke, as they may worsen outcomes; they should be avoided unless concurrent inflammatory disease is confirmed
• ·Anticoagulation / antiplatelet therapy: Clopidogrel or aspirin may be considered in selected cases to reduce recurrence risk, particularly in cats with cardiac disease or hypercoagulable states; risk-benefit must be carefully weighed
• ·Anticonvulsants: Phenobarbital or levetiracetam if seizures occur acutely or post-infarction
• ·Anti-nausea medications: Maropitant or meclizine for vestibular-associated nausea and vomiting
• ·IV fluid support: Judicious crystalloid support to maintain adequate cerebral perfusion pressure, avoiding overhydration in hypertensive patients

Nursing and Supportive Care

• ·Provision of soft, padded bedding to prevent decubital ulcers in recumbent patients
• ·Assisted feeding (syringe feeding, esophagostomy tube) if the cat is unable to eat independently
• ·Regular physiotherapy and passive limb exercises to maintain muscle mass and joint mobility
• ·Bladder management (manual expression or urinary catheter) in patients with urinary retention
• ·Environmental modification to minimize injury risk (e.g., padded enclosures for rolling/ataxic patients)
• ·Monitoring for aspiration pneumonia, particularly in cats with dysphagia

General Prognosis

The prognosis for feline ischemic stroke is guarded to fair and is heavily influenced by the size and location of the infarct, the severity of neurological deficits at presentation, and the presence and manageability of an underlying cause [1]. Many cats show spontaneous neurological improvement over days to weeks as the penumbra recovers and brain plasticity allows partial functional compensation.

Neurological Recovery

Experimental MCA occlusion studies in cats demonstrate that the degree of neurological deficit and EEG suppression immediately following the ischemic event correlates with both the extent of morphological brain damage and the likelihood of recovery [3]. Cats with mild-to-moderate neurological deficits generally have a better prognosis for functional recovery than those presenting in stupor or coma. The non-progressive nature of the deficits (in contrast to expanding neoplasia) is a favorable prognostic indicator.

Survival and Mortality Data

The provided reference literature does not include explicit case-fatality rates or survival statistics specifically for clinical feline ischemic stroke cases. The available experimental studies focus on pathophysiological mechanisms rather than clinical outcome statistics [3] [5]. Based on general veterinary neurological literature principles cited herein, the following observations apply:

• ·Cats with ischemic stroke secondary to a treatable underlying condition (e.g., controlled hypertension, treated hyperthyroidism) have a meaningfully better long-term outlook than those with untreatable or unidentified causes
• ·Recurrence is possible, particularly if an underlying predisposing condition (e.g., hypertension, cardiac disease) is not adequately controlled [1]
• ·Severely affected cats (comatose, absent brainstem reflexes, or with very large infarcts) carry a grave prognosis

Data on precise long-term survival statistics and mortality rates for clinical feline ischemic stroke are limited in the current veterinary literature; no peer-reviewed survival percentage for this condition was identified in the references cited above.

Primary Prevention: Addressing Risk Factors

Because feline ischemic stroke most commonly occurs secondary to identifiable systemic diseases, prevention focuses on early detection and management of predisposing conditions [1]:

• ·Regular blood pressure monitoring: Especially in cats over 7 years of age, and in any cat with known CKD, hyperthyroidism, or cardiac disease; early identification and treatment of hypertension is the single most impactful preventive measure
• ·Annual or biannual veterinary wellness examinations: Including thyroid function testing (total T4) in middle-aged and senior cats to detect hyperthyroidism early
• ·Routine renal function assessment: Serum BUN, creatinine, and urine protein:creatinine ratio to identify CKD and associated hypertension or proteinuria
• ·Echocardiographic screening: In breeds predisposed to hypertrophic cardiomyopathy (e.g., Maine Coon, Ragdoll, British Shorthair), as cardiac thrombi are a potential embolic source
• ·Antiplatelet prophylaxis: Clopidogrel is recommended for cats with cardiomyopathy at risk of arterial thromboembolism, which may incidentally reduce cerebrovascular thrombotic risk
• ·Weight management: Obesity contributes to hypertension and metabolic disease; maintaining a healthy body weight reduces overall cardiovascular risk

Secondary Prevention (Reducing Recurrence)

• ·Once a stroke has occurred, aggressive management of the identified underlying cause is essential to reduce recurrence risk
• ·Ongoing blood pressure monitoring and antihypertensive titration
• ·Owner education regarding recognition of recurrent neurological signs warranting emergency re-evaluation

Vaccination

There are no vaccines applicable to the prevention of ischemic stroke in cats. Routine vaccination against common infectious diseases (FHV-1, FCV, FPV, rabies) supports general health but does not directly prevent cerebrovascular events.